Results 11 to 20 of about 9,764 (249)

Non‐Langerhans cell histiocytosis xanthogranuloma patient with varying histopathology leading to progressive nodular histiocytosis

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2021
restriction
Yeongjoo Oh, Jemin Kim, Chang Ook Park
openalex   +5 more sources

Intermediate-dose cytarabine is an effective therapy for adults with non-Langerhans cell histiocytosis [PDF]

Orphanet Journal of Rare Diseases, 2021
Abstract Background Non-Langerhans cell histiocytosis, including Erdheim–Chester disease (ECD), Rosai–Dorfman disease (RDD), indeterminate cell histiocytosis (ICH), and unclassified histiocytosis, is a rare disorder lacking a standard treatment strategy.
Ting Liu, Huacong Cai, Hao Cai, Miao Chen, Wei Zhang, Li J, Daobin Zhou, Xinxin Cao   +7 more
openalex   +5 more sources

An unusual case of intracerebral Non-Langerhans cell histiocytosis with review of the literature [PDF]

Diagnostic Pathology, 2007
Conclusion This case shows the unusual manifestation of a primary intracerebral Non-Langerhans cell histiocytosis, which begins as a solid mass around the sellar region and shows a remarkable extension as a flat lining of inner and outer liquor spaces.
Klaus Mueller, Mafalda Trippel, Ansgar Berlis, Wibke G. Janzarik, B Volk   +4 more
openalex   +4 more sources

Erdheim- Chester Disease (Non-Langerhans Cell Histiocytosis)

Journal of Cancer Research Reviews & Reports
52 years old female with recurrent admission for myalgias, inflammatory arthritis, rash around the eyes and abdomen (A, B). Routine blood tests were either normal or negative apart from low C4 level. Pan CT of the body was unremarkable.
Yousef Gulnaz, Adel Ekladious
openalex   +2 more sources

Novel actionable ROS1::GIT2 fusion in non-Langerhans cell histiocytosis with central nervous system involvement. [PDF]

Acta Neuropathol, 2023
Bedics G, Csóka M, Reiniger L, Varga E, Liptai Z, Papp G, Bekő A, Cervi C, Bödör C, Scheich B.   +9 more
europepmc   +3 more sources

Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis. [PDF]

Mol Cancer Ther, 2019
Janku F, Diamond EL, Goodman AM, Raghavan VK, Barnes TG, Kato S, Abdel-Wahab O, Durham BH, Meric-Bernstam F, Kurzrock R.   +9 more
europepmc   +3 more sources

Non Langerhans Cell Histiocytosis of the Rectum: Case Report and Review of the Literature

Japanese Journal of Gastroenterology and Hepatology, 2022
Histiocytosis is a condition resulting from the abnormal proliferation of dentritic cells of the mononuclear phagocytic system. Previously classified as Langerhans cell histiocytosis and non-Langerhans cell histiocytosis, and recently into 5 categories (L, C, R, M and H), it can be localized to an organ or have a systemic manifestation, affecting most ...
Malek Michael Bouhairie, J Mansour, El Naderi S, Abou Rached A   +3 more
openalex   +2 more sources

Disseminated non-Langerhans cell histiocytosis with an IRF2BP2-NTRK1 gene fusion identified by next-generation sequencing. [PDF]

JAAD Case Rep, 2020
Chan WH, Shah A, Bae G, Hambro C, Martin BA, Brown R, Novoa R, Kwong BY.   +7 more
europepmc   +2 more sources

A rare cutaneous lesion in the neonatal period: The non-Langerhans cell histiocytosis

Marmara Medical Journal, 2020
The non-Langerhans cell histiocytosis (non-LCH) is a group of diseases characterized by cutaneous involvement in the neonatal period. The non-LCH affects less than 1 in 200,000 children born each year. A definitive diagnosis is important for the treatment of the disease.
Adnan Barutçu, Ferda Özlü, Hacer Yapıcıoğlu Yıldızdaş, Mehmet Satar   +3 more
openalex   +4 more sources

Histiocyte Society blueprint for non-Langerhans cell histiocytosis research: unraveling complex diseases through collaboration. [PDF]

Haematologica
Hershkovitz-Rokah O, Abeykoon JP, Ravindran A, Goyal G.   +3 more
europepmc   +3 more sources